Coronary artery disease (CAD) is one of the major causes of mortality and morbidity worldwide, with a high socioeconomic impact.(1) Non-invasive imaging modalities play a fundamental role in the evaluation and management of patients with known or suspected CAD. Imaging end-points have served as surrogate markers in many observational studies and randomized clinical trials that evaluated the benefits of specific therapies for CAD.(2) A number of guidelines and recommendations have been published about coronary syndromes by cardiology societies and associations, but have not focused on the excellent opportunities with cardiac imaging. The recent European Society of Cardiology (ESC) 2019 guideline on chronic coronary syndromes (CCS) and 2020 guideline on acute coronary syndromes in patients presenting with non-ST-segment elevation (NSTE-ACS) highlight the importance of non-invasive imaging in the diagnosis, treatment, and risk assessment of the disease.(3)(4) The purpose of the current recommendations is to present the significant role of non-invasive imaging in coronary syndromes in more detail. These recommendations have been developed by the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE), in collaboration with the American Society of Nuclear Cardiology, the Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance, all of which have approved the final document.

中文翻译：

---

冠状动脉综合征的无创成像：欧洲心血管成像协会和美国超声心动图学会与美国核心脏病学会、心血管计算机断层扫描学会和心血管磁共振学会合作的建议。

冠状动脉疾病 (CAD) 是全球死亡率和发病率的主要原因之一，具有很高的社会经济影响。(1) 无创成像方式在已知或疑似 CAD 患者的评估和管理中发挥着重要作用。在许多评估 CAD 特定疗法的益处的观察性研究和随机临床试验中，影像学终点已作为替代标志物。(2) 心脏病学会和协会已经发表了许多关于冠状动脉综合征的指南和建议，但没有专注于心脏成像的绝佳机会。最近的欧洲心脏病学会 (ESC) 2019 年慢性冠状动脉综合征 (CCS) 指南和 2020 年非 ST 段抬高患者急性冠状动脉综合征指南 (NSTE-ACS) 强调了无创成像在心血管疾病中的重要性。疾病的诊断、治疗和风险评估。(3)(4) 当前建议的目的是更详细地介绍无创成像在冠状动脉综合征中的重要作用。这些建议由欧洲心血管成像协会 (EACVI) 和美国超声心动图协会 (ASE) 与美国核心脏病学会、心血管计算机断层扫描学会和心血管磁共振学会合作制定，所有这些都批准了最终文件。